Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction

This publication has 24 references indexed in Scilit:

• Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction
  Circulation, 2002
• Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction
  Journal of the American College of Cardiology, 2002
• Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents. A comparison of TNK-tPA and rt-PA
  Published by Oxford University Press (OUP) ,2001
• Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
  The Lancet, 2001
• Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14
  European Heart Journal, 2000
• Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction. A phase II dose escalation, randomized, double-blind study
  Published by Oxford University Press (OUP) ,2000
• St-segment resolution and infarct-related artery patency and flow after thrombolytic therapy
  The American Journal of Cardiology, 2000
• Overcoming thrombolytic resistance: Rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarction
  Journal of the American College of Cardiology, 1999
• 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction
  Journal of the American College of Cardiology, 1999
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1993